As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage.
By providing infrastructure, services, educational programs and networks in global hotspots, JLABS is the best place to start a company working in healthcare, with a specific emphasis on Johnson & Johnson’s sectors: consumer, medical device and pharmaceuticals.
It can be tricky to communicate the full potential of your discoveries without spilling the secret sauce, let alone present virtually! Join us for presentations with the aim to give the tricks of the trade in preparing a non-confidential deck and executive summary along with tips that are aimed to help you sell your science for in person meetings or virtually.
Kara Bortone, PhD, Senior Director, Portfolio & Sourcing Management at Johnson & Johnson Innovation- JLABS will share practical tips with the aim to help you become more effective in communicating your story to Angel investors and VCs, increasing your chances of successful fundraising. Matt Bresnahan, Wilson Sonsini Goodrich & Rosati will discuss details on how to develop a pitch deck that communicates the value of your company to investors while protecting your IP.
After the presentations, join us for a Q&A discussion where presenters answer your questions and share their experiences on best practices and pet peeves when it comes to pitching and presenting your science.
Kara is responsible for setting the strategic direction and overseeing all pipeline activities for sourcing, selection, screening, onboarding, optimizing and tracking the portfolio across JLABS globally. Kara joined the JLABS team in 2012, shortly after the flagship JLABS site opened at Janssen R&D in San Diego. In her previous role, Kara executed on external engagement, sourcing innovation, portfolio management, operational excellence, educational programming, and P&L for the JLABS in San Diego site.
Matt Bresnahan is a partner in the San Diego and Los Angeles offices of Wilson Sonsini Goodrich & Rosati, where he has focused his practice over the past 12 years on all aspects of intellectual property, including strategic patent counseling, patent prosecution, licensing, and litigation. Matt is primary outside IP counsel to more than 50 life sciences companies within the biotechnology, molecular biology, pharmaceutical, diagnostic, and medical device fields in Southern California.
